v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 85,930 $ 115,019
Prepaid expenses and other current assets 11,854 26,592
Total current assets 97,784 141,611
Total assets 97,784 141,611
Current liabilities:    
Accounts payable 138,129 134,865
Accrued compensation 3,888,949 3,767,652
Accrued consulting 787,903 787,903
Accrued expenses and other 641,700 646,850
Loan payable 200,000 200,000
Total current liabilities 5,656,681 5,537,270
Convertible notes, net 1,410,597 1,392,515
Total liabilities 7,067,278 6,929,785
Commitments and contingencies  
Stockholders’ deficit:    
Preferred stock, value
Common stock, $0.00001 par value: 100,000,000 shares authorized: 7,242,137 shares issued and outstanding 72 72
Additional paid-in capital 2,050,073 2,050,073
Accumulated deficit (9,019,640) (8,838,320)
Total stockholders’ deficit (6,969,494) (6,788,174)
Total liabilities and stockholders’ deficit 97,784 141,611
Series A Preferred Stock [Member]    
Stockholders’ deficit:    
Preferred stock, value 0 0
Series B Preferred Stock [Member]    
Stockholders’ deficit:    
Preferred stock, value $ 1 $ 1